Multiple Sclerosis
MS Briefs
Serum vitamin D inversely associated with clinical and disease activity in MS
MS Briefs
MS in pregnancy: Maintenance of natalizumab during the first trimester is beneficial
MS Briefs
High serum homocysteine levels in patients with MS
MS Briefs
Cancer risks with biological therapies for MS
MS Briefs
MS: Trends in the use of disease-modifying agents
News
FDA approves ozanimod for relapsing and secondary progressive forms of MS
It is the only approved sphingosine-1-phosphate receptor modulator with no requirement for genetic testing or label-based first-dose observation...